BCL-2 inhibitors have the potential to hinder viremia in viral infections where BCL-2 anti-apoptotic proteins are upregulated, but when these anti-apoptotic proteins are downregulated a BCL-2 inhibitor could aid infection and have drastic effects on a patient’s health. The gene discussed is BCL2; the disease is viral infectious disease.